Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Globus Medical Merges With NuVasive in $3.1 Billion Deal

Globus Medical Merges With NuVasive in $3.1 Billion Deal

Globus Medical has announced its merger with San Diego-based NuVasive, Inc. in an all-stock deal valued at $3.1 billion. Following the close of the transaction, Globus Medical shareholders will own about 72% of the combined company and NuVasive shareholders will own the remaining 28%. NuVasive will allow Globus to support more patients and expand its commercial reach in the $50 billion global musculoskeletal market. The combined company will have an 11-member board composed of all eight directors from Globus Medical’s board and three directors from NuVasive’s board. The deal is expected to be completed by mid-2023. NuVasive is a medical device company based in San Diego. The... Read More »
India’s MediBuddy Acquires vHealth From Aetna

India’s MediBuddy Acquires vHealth From Aetna

MediBuddy has acquired Dehli, India-based vHealth from Aetna Inc. Over the next six months, vHealth will transition to be rebranded as MediBuddy vHealth. Terms of the deal were not disclosed. vHealth is the India-based health business of Aetna Inc., a CVS Health company. vHealth offers subscription-based primary healthcare services such as telehealth consultations, an outpatient network, pharmacy, diagnostics and dental as well as other benefits. Bangalore, India-based MediBuddy is a healthtech platform that was founded in 2013 by Satish Kannan and Enbasekar Dinadayalane. It has a network of 2,500 pharmacies, 3,000 diagnostic centers, 7,000 hospitals and 90,000 doctors in several Indian... Read More »
Abbott Acquires Cardiovascular Systems for $890 Million

Abbott Acquires Cardiovascular Systems for $890 Million

Abbott is expanding its cardiovascular device portfolio with its acquisition of Cardiovascular Systems. Under terms of the agreement, Cardiovascular Systems’ stockholders will receive $20 per common share at a total expected equity value of approximately $890 million. J.P. Morgan Securities LLC served as the financial advisor to Cardiovascular Systems. The transaction is expected to be neutral to Abbott’s 2023 ongoing earnings per share guidance. Cardiovascular Systems is a medical device company focused on the development and commercialization of solutions for treating complex peripheral vascular disease and coronary artery disease. Abbott manufactures and sells healthcare... Read More »
ImageTrend Announces Strategic Growth Investment From WCAS

ImageTrend Announces Strategic Growth Investment From WCAS

ImageTrend, Inc. announced an equity investment from Welsh, Carson, Anderson & Stowe (WCAS). Robert W. Baird & Co. acted as the financial advisor for ImageTrend. Kirkland & Ellis LLP served as legal counsel and Shea & Co. served as financial advisor to WCAS. Terms of the deal were not disclosed. ImageTrend delivers software solutions, data analytics and services for EMS departments, hospitals, community paramedicine (CP), critical care, fire and preparedness functions to enable fully integrated patient-centric healthcare and public safety. WCAS is a private equity firm focused on two target industries, technology and health care. Since its founding in 1979, the firm has... Read More »
GE Healthcare Acquires Caption Health

GE Healthcare Acquires Caption Health

GE Healthcare has acquired Caption Health, Inc. The transaction is subject to customary closing conditions. Financial terms of the deal are not being disclosed. GE Healthcare intends to fund this transaction with cash on hand. Caption Health is a privately owned artificial intelligence (AI) healthcare company that creates clinical applications to aid in early disease detection, using AI to assist in conducting ultrasound scans. GE Healthcare, a subsidiary of GE, manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. According to data captured in the LevinPro HC database, this acquisition represents... Read More »
Medline Acquires ShiftKey

Medline Acquires ShiftKey

Northfield, Illinois-based Medline Industries, Inc. has acquired ShiftKey, which is based in Irving, Texas. ShiftKey integrates with a solution in Medline’s tech portfolio, OnShift, an end-to-end workforce engagement platform. This integration provides a view of the schedule, including facility employees, agency workers and those on the ShiftKey platform all in one place. Prior to this transaction, ShiftKey made a strategic investment in OnShift to further complement its workforce technologies. Terms of the deal were not disclosed.  ShiftKey is a scheduling and credential management platform designed to combat the national healthcare staffing shortage by empowering healthcare... Read More »
Ampersand-Backed Sterling Medical Devices Merges With RBC Medical Innovations

Ampersand-Backed Sterling Medical Devices Merges With RBC Medical Innovations

Sterling Medical Devices, a portfolio company of private equity firm Ampersand Capital Partners, announced on February 8 its recapitalization and simultaneous merger with RBC Medical Innovations. RBC brings additional design and development capacity, including expertise in energy-based electromechanical devices, as well as manufacturing capabilities to the combined organization. As part of the transaction, MedTech industry executive David Montecalvo has been appointed CEO of the combined company. Sterling Founder Dan Sterling will remain on the senior leadership team and a board director. RBC Founder Carl Mayer has joined the board of directors. RBC Medical Innovations is a medical device... Read More »
CVS Health Acquires Oak Street Health for $10.6 Billion

CVS Health Acquires Oak Street Health for $10.6 Billion

CVS Health announced on February 8 its acquisition of Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion. This marks CVS Health’s third largest deal in the last decade and fourth in the company’s history. With the purchase of Oak Street Health, CVS Health will control more than 160 primary care centers that offer routine health screenings and diagnosis to adults. Oak Street Health is a health care network of primary care centers for older adults on Medicare. The company leverages value-based care payment structures to improve outcomes and curb cost. Oak Street Health, which went public in 2020, operates... Read More »
PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm

PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm

Chicago-based private equity firm Shore Capital Partners announced the sale of Argentum Medical to BioDerm, a portfolio company of Denver-based private equity firm Mountaingate Capital. The transaction closed on January 31, 2023. Moelis & Company served as financial advisor to Argentum and Winston & Strawn LLP served as legal advisor to Shore and Argentum. Terms of the deal were not disclosed. Based in Geneva, Illinois, Argentum is a provider of infection prevention solutions for the management of wounds. Notably, it manufactures Silverlon, a silver-plated nylon dressing with unique antimicrobial properties. Argentum’s product lines include surgical, burn care, wound care, negative... Read More »
Avania Acquires MAXIS

Avania Acquires MAXIS

Avania, which is headquartered in the Netherlands, has acquired San Jose, California-based MAXIS. MAXIS’ clients will benefit from Avania’s international footprint, gaining access to the company’s network in the U.S., EU and Australia. Avania brings enhanced services to the combined company — including biostatistics, data analytics and medical writing. Terms of the deal were not disclosed. Avania is a contract research organization with specialized expertise in medical devices, novel technology and combination products. It advances products from feasibility through post-approval trials in analytics, clinical trials, consulting, regulatory and reimbursement. MAXIS is a medical technology... Read More »